文献速递糖尿病

血糖控制良好的T2D及非糖尿病慢性胰腺炎患者的β细胞去分化

β-Cell Dedifferentiation in Patients With T2D With Adequate Glucose Control and Nondiabetic Chronic Pancreatitis.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

本研究检测了9例非糖尿病对照、10例空腹血糖控制良好的糖尿病患者及4例非糖尿病慢性胰腺炎(NDCP)患者的胰岛,发现T2D患者去分化细胞比例较对照升高近三倍(10.0% vs 3.6%,P<0.0001),且与糖尿病病程正相关;NDCP中去分化细胞比例达10.4%,与炎症浸润、纤维化及萎缩分级相关。

要点

  • 血糖控制良好的T2D患者胰岛去分化细胞比例较非糖尿病对照升高近三倍(10.0% vs 3.6%,P<0.0001)。
  • 去分化率与糖尿病病程呈正相关。
  • NDCP患者中去分化细胞比例为10.4%,与炎症细胞浸润、纤维化及萎缩分级相关。

核心结论

  • 数据支持血糖控制良好的T2D患者胰岛β细胞发生去分化的观点。
  • NDCP中大量去分化细胞的存在提示炎症诱导的β细胞去分化可能是疾病进展中胰源性糖尿病的病因。

研究设计与样本

  • examination of pancreatic islets from nine nondiabetic controls, 10 patients with diabetes with well-controlled fasting glycemia, and four individuals with NDCP.
  • 计算激素阴性内分泌细胞及多激素内分泌细胞的百分比,并对炎症细胞浸润、纤维化、萎缩及脂肪变性进行病理评分。

主要发现

  • T2D with adequate glucose control compared with nondiabetic controls: dedifferentiated cells 10.0% vs 3.6% (P < 0.0001), nearly threefold increase.
  • 去分化率与糖尿病病程呈正相关。
  • NDCP中去分化细胞比例为10.4%,与炎症细胞浸润、纤维化及萎缩分级良好相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Type 2 diabetes (T2D) and pancreatogenic diabetes are both associated with loss of functional β-cell mass. Previous studies have proposed β-cell dedifferentiation as a mechanism of islet β-cell failure, but its significance in humans is still controversial. OBJECTIVE: To determine whether β-cell dedifferentiation occurs in human T2D with adequate glucose control and in nondiabetic chronic pancreatitis (NDCP), we examined pancreatic islets from nine nondiabetic controls, 10 patients with diabetes with well-controlled fasting glycemia, and four individuals with NDCP. DESIGN: We calculated the percentage of hormone-negative endocrine cells and multihormone endocrine cells and scored the pathological characteristics; that is, inflammatory cell infiltration, fibrosis, atrophy, and steatosis, in each case. RESULTS: We found a nearly threefold increase in dedifferentiated cells in T2D with adequate glucose control compared with nondiabetic controls (10.0% vs 3.6%, T2D vs nondiabetic controls, P < 0.0001). The dedifferentiation rate was positively correlated with the duration of diabetes. Moreover, we detected a considerable proportion of dedifferentiated cells in NDCP (10.4%), which correlated well with the grade of inflammatory cell infiltration, fibrosis, and atrophy. CONCLUSIONS: The data support the view that pancreatic β-cells are dedifferentiated in patients with T2D with adequate glucose control. Furthermore, the existence of abundant dedifferentiated cells in NDCP suggests that inflammation-induced β-cell dedifferentiation can be a cause of pancreatogenic diabetes during disease progress.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sun J, Ni Q, Xie J, et al. β-Cell Dedifferentiation in Patients With T2D With Adequate Glucose Control and Nondiabetic Chronic Pancreatitis. J Clin Endocrinol Metab. 2019. PMID: 30085195. doi:10.1210/jc.2018-00968

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。